| Biogen Switzerland AG - Spinraza 50mg/5ml, Injektionslösung zur intrathekalen Injektion |
| 66495 | | 03 | | Spinraza 50mg/5ml | | Injektionslösung zur intrathekalen Injektion | | M09AX | | Other Drugs for Disorders Of The Musculo-Skeletal System | | 19.02.2026 | | |
|
| Composition |
| nusinersenum 50 mg ut nusinersenum natricum, natrii dihydrogenophosphas dihydricus, dinatrii phosphas, natrii chloridum, kalii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, natrii hydroxidum ad pH, acidum hydrochloridum ad pH, aqua ad iniectabile q.s. ad solutionem pro 5 ml corresp. natrium max. 19.2 mg et kalium 0.59 mg. |
| Packungsbestandteile |
| Injektionslösung zur intrathekalen Injektion | | | | | | | | Active Agent | Dose |
|---|
| Nusinersenum | 50mg / 5ml |
| | BAG: Active Agent | Dose |
|---|
| Nusinersenum | 50 mg |
| | | | Inactive agents |
|---|
| Acidum Hydrochloridum ad Ph | | Calcii Chloridum Dihydricum | | Disodium Phosphate | | Kalii Chloridum | | Magnesium Chloride Hexahydrate | | Sodium Chloride | | Sodium Dihydrogenophosphate Dihydrate | | Natrii Hydroxidum ad Ph |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | 5 ml | 136219.41 | 140068.90 | A | SL | No |
|
